•
Oct 31, 2019

Summit Therapeutics Q3 2019 Earnings Report

Total Revenue
$153K
Previous year: $863K
-82.3%
EPS
-$0.05
Previous year: -$0.13
-61.5%
Gross Profit
$160K
Cash and Equivalents
$21.6M
Free Cash Flow
-$4.76M

Summit Therapeutics

Summit Therapeutics